Patents Assigned to DexCom, Inc.
  • Analyte sensor
    Patent number: 10993642
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: November 3, 2020
    Date of Patent: May 4, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin
  • Remote monitoring of analyte measurements
    Patent number: 10993617
    Abstract: Methods and apparatus, including computer program products, are provided for remote monitoring. In some example implementations, there is provided a method. The method may include receiving, at a remote monitor, a notification message representative of an event detected, by a server, from analyte sensor data obtained from a receiver monitoring an analyte state of a host; presenting, at the remote monitor, the notification message to activate the remote monitor, wherein the remote monitor is configured by the server to receive the notification message to augment the receiver monitoring of the analyte state of the host; accessing, by the remote monitor, the server, in response to the presenting of the notification message; and receiving, in response to the accessing, information including at least the analyte sensor data. Related systems, methods, and articles of manufacture are also disclosed.
    Type: Grant
    Filed: July 21, 2020
    Date of Patent: May 4, 2021
    Assignee: DexCom, Inc.
    Inventors: Michael Robert Mensinger, Eric Cohen, Phil Mayou, Eli Reihman, Katherine Yerre Koehler, Rian Draeger, Angela Marie Traven
  • Analyte sensor
    Patent number: 10993641
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: May 4, 2021
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, James Patrick Thrower, Paul V. Goode, Jr.
  • Reporting modules
    Patent number: 10998098
    Abstract: Methods and apparatus, including computer program products, are provided for processing analyte data. In some exemplary implementations, there is provided a method. The method may include generating, by at least one processor, a view comprising an abstraction distilled from the sensor data over a time period. The view may further comprise a graphical representation comprising a plurality of different graphically distinct elements representative of whether the abstraction over the time period is at least one of at, above, or within a predetermined glucose concentration level for a host; a call out comprising value help for the graphical representation, and a textual legend comprising a description of the graphical representation and the abstraction. The method may further include providing the view as a module. Related systems, methods, and articles of manufacture are also disclosed.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: May 4, 2021
    Assignee: DexCom, Inc.
    Inventors: Adam R. Greene, Justin E. Schumacher, Daniel N. Root
  • Systems and methods for processing analyte sensor data
    Patent number: 10987040
    Abstract: Systems and methods for applying time-dependent algorithmic compensation functions to data output from a continuous analyte sensor. Some embodiments determine a time since sensor implantation and/or whether a newly initialized sensor has been used previously.
    Type: Grant
    Filed: June 13, 2017
    Date of Patent: April 27, 2021
    Assignee: DexCom, Inc.
    Inventors: Michael J. Estes, Stephen J. Vanslyke, Apurv Ullas Kamath, Thomas A. Peyser, Lucas Bohnett, Aarthi Mahalingam, Arturo Garcia, Peter C. Simpson, Anna Leigh Davis, Sebastian Böhm
  • Analyte sensor
    Patent number: 10980452
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: November 3, 2020
    Date of Patent: April 20, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Apurv Ullas Kamath, Steve Masterson, Aarthi Mahalingam, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Vance Swanson, Matthew D. Wightlin
  • Systems and methods for display device and sensor electronics unit communication
    Patent number: 10980450
    Abstract: Methods and apparatus are provided for communication among display devices and sensor electronics unit in an analyte monitoring system. The analyte monitoring system may include a sensor that is configured to perform measurements indicative of analyte levels. The sensor may be communicatively coupled to the sensor electronics unit. The sensor electronics unit may be configured to transmit data indicative of analyte levels to the display devices using one or more communication protocols. Furthermore, the sensor electronics unit may be configured to operate in multiple modes, and switch between the modes in response to commands received from the display devices. Related systems, methods, and articles of manufacture are also described.
    Type: Grant
    Filed: September 8, 2020
    Date of Patent: April 20, 2021
    Assignee: DexCom, Inc.
    Inventors: Jeffrey R. Wedekind, Douglas William Burnette, Aditya Mandapaka, Zebediah L. McDaniel, Peter C. Simpson, Arturo Garcia
  • Methods for providing an alert or an alarm to a user of a mobile communications device
    Patent number: 10980941
    Abstract: A computer-readable medium on a mobile computing device comprises an inter-application communication data structure to facilitate transitioning and distributing data between software applications in a shared app group for an operating system of the mobile computing device includes a scheme field of the data structure providing a scheme id associated with a target software app to transition to from a source software app, wherein the scheme id is listed on a scheme list stored with the source software app; and a payload field of the data structure providing data and/or an identification where to access data in a shared file system accessible to the software applications in the shared app group, wherein the payload field is encrypted.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: April 20, 2021
    Assignee: DexCom, Inc.
    Inventors: Gary A. Morris, Scott M. Belliveau, Esteban Cabrera, Jr., Rian Draeger, Laura J. Dunn, Timothy Joseph Goldsmith, Hari Hampapuram, Christopher Robert Hannemann, Apurv Ullas Kamath, Katherine Yerre Koehler, Patrick Wile McBride, Michael Robert Mensinger, Francis William Pascual, Philip Mansiel Pellouchoud, Nicholas Polytaridis, Philip Thomas Pupa, Anna Leigh Davis, Kevin Shoemaker, Brian Christopher Smith, Benjamin Elrod West, Atiim Joseph Wiley
  • Systems and methods for display device and sensor electronics unit communication
    Patent number: 10980453
    Abstract: Methods and apparatus are provided for communication among display devices and sensor electronics unit in an analyte monitoring system. The analyte monitoring system may include a sensor that is configured to perform measurements indicative of analyte levels. The sensor may be communicatively coupled to the sensor electronics unit. The sensor electronics unit may be configured to transmit data indicative of analyte levels to the display devices using one or more communication protocols. Furthermore, the sensor electronics unit may be configured to operate in multiple modes, and switch between the modes in response to commands received from the display devices. Related systems, methods, and articles of manufacture are also described.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: April 20, 2021
    Assignee: DexCom, Inc.
    Inventors: Jeffrey R. Wedekind, Douglas William Burnette, Aditya Mandapaka, Zebediah L. McDaniel, Peter C. Simpson, Arturo Garcia
  • Advanced analyte sensor calibration and error detection
    Patent number: 10980461
    Abstract: Systems and methods for processing sensor data and self-calibration are provided. In some embodiments, systems and methods are provided which are capable of calibrating a continuous analyte sensor based on an initial sensitivity, and then continuously performing self-calibration without using, or with reduced use of, reference measurements. In certain embodiments, a sensitivity of the analyte sensor is determined by applying an estimative algorithm that is a function of certain parameters. Also described herein are systems and methods for determining a property of an analyte sensor using a stimulus signal. The sensor property can be used to compensate sensor data for sensitivity drift, or determine another property associated with the sensor, such as temperature, sensor membrane damage, moisture ingress in sensor electronics, and scaling factors.
    Type: Grant
    Filed: October 28, 2020
    Date of Patent: April 20, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Ying Li, Apurv Ullas Kamath, Richard C. Yang
  • Systems and methods for display device and sensor electronics unit communication
    Patent number: 10980451
    Abstract: Methods and apparatus are provided for communication among display devices and sensor electronics unit in an analyte monitoring system. The analyte monitoring system may include a sensor that is configured to perform measurements indicative of analyte levels. The sensor may be communicatively coupled to the sensor electronics unit. The sensor electronics unit may be configured to transmit data indicative of analyte levels to the display devices using one or more communication protocols. Furthermore, the sensor electronics unit may be configured to operate in multiple modes, and switch between the modes in response to commands received from the display devices. Related systems, methods, and articles of manufacture are also described.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: April 20, 2021
    Assignee: DexCom, Inc.
    Inventors: Jeffrey R. Wedekind, Douglas William Burnette, Aditya Mandapaka, Zebediah L. McDaniel, Peter C. Simpson, Arturo Garcia
  • Systems and methods for processing and transmitting sensor data
    Patent number: 10985804
    Abstract: Systems and methods for processing, transmitting and displaying data received from an analyte sensor, such as a glucose sensor, are disclosed. In an embodiment, a method for transmitting data between a first communication device associated with an analyte sensor and a second communication device configured to provide user access to sensor-related information comprises: activating a transceiver of a first communication device associated with an analyte sensor at a first time; and establishing a two-way communication channel with the second communication device; wherein the activating comprises waking the transceiver from a low power sleep mode using a forced wakeup from the second communication device.
    Type: Grant
    Filed: July 9, 2020
    Date of Patent: April 20, 2021
    Assignee: DexCom, Inc.
    Inventors: Thomas Miller, Mark Dervaes, Phong Lieu, Peter C. Simpson, Shawn Larvenz, Jacob S. Leach, Sebastian Bohm
  • Diabetes management partner interface for wireless communication of analyte data
    Patent number: 10979431
    Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. In embodiments, a method of using a diabetes management partner interface to configure an analyte sensor system for wireless communication with a plurality of partner devices is provided. The method includes the analyte sensor system receiving authorization to provide one of the partner devices with access to a set of configuration parameters via the diabetes management partner interface. The set of configuration parameters is stored in a memory of the analyte sensor system. The method also includes, responsive to input received from the one partner device via the diabetes management partner interface, the analyte sensor system setting or causing a modification to the set of configuration parameters, according to a system requirement of the one partner device.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: April 13, 2021
    Assignee: DexCom, Inc.
    Inventors: Apurv Ullas Kamath, Michael Robert Mensinger, Nicholas Polytaridis, Gary A. Morris, Alexandra Elena Constatin, Douglas William Burnette, Mario Remon, Jorge R. Barreras, Benjamin Elrod West, Christopher Robert Hannemann
  • Integrated medicament delivery device for use with continuous analyte sensor
    Patent number: 10966609
    Abstract: An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: April 6, 2021
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Nelson Quintana, Antonio C. Llevares, John Michael Dobbles, Richard C. Yang, Michael Robert Mensinger
  • Systems and methods for distributing continuous glucose data
    Patent number: 10945600
    Abstract: The present disclosure relates to systems, devices and methods for receiving biosensor data acquired by a medical device, e.g., relating to glucose concentration values, and controlling the access and distribution of that data. In some embodiments, systems and methods are disclosed for monitoring glucose levels, displaying data relating to glucose values and metabolic health information, and controlling distribution of glucose data between applications executing on a computer, such as a smart phone. In some embodiments, systems and methods are disclosed for controlling access to medical data such as continuously monitored glucose levels, synchronizing health data relating to glucose levels between multiple applications executing on a computer, and/or encrypting data.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: March 16, 2021
    Assignee: DexCom, Inc.
    Inventors: Michael Robert Mensinger, Esteban Cabrera, Jr., Eric Cohen, Nathaniel David Heintzman, Apurv Ullas Kamath, Gary A. Morris, Andrew Attila Pal, Eli Reihman, Jorge Valdes
  • Analyte sensor
    Patent number: 10932700
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: July 8, 2020
    Date of Patent: March 2, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin
  • Invasive biosensor alignment and retention
    Patent number: 10932699
    Abstract: Examples of invasive biosensor alignment and retention features and methods are described. One example biosensor includes a housing comprising: a first surface defining a first opening, and a second surface opposite the first surface, the second surface defining a second opening, the first and second openings defining a substantially unobstructed pathway through the housing; a biosensor wire partially disposed within the housing and having an exterior portion extending through the first opening; a hollow insertion needle positioned within the pathway and extending through the first opening, the hollow insertion needle at least partially encircling the biosensor wire; and a biosensor retention feature collapsible against the first surface of the housing, the biosensor retention feature encircling and contacting the hollow insertion needle.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: March 2, 2021
    Assignee: DEXCOM, INC.
    Inventors: Arthur Lin, Xianyan Wang, Pey-Jiun Ko
  • Sensors for continuous analyte monitoring, and related methods
    Patent number: 10932709
    Abstract: Sensor devices including dissolvable tissue-piercing tips are provided. The sensor devices can be used in conjunction with dissolvable needles configured for inserting the sensor devices into a host. Hardening agents for strengthening membranes on sensor devices are also provided. Methods of using and fabricating sensor devices are also provided.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: March 2, 2021
    Assignee: DEXCOM, INC.
    Inventors: Peter C. Simpson, Jennifer Blackwell, Sebastian Bohm, Michael J. Estes, Jeff Jackson, Jason Mitchell, Jack Pryor, Daiting Rong, Sean T. Saint, Disha B. Sheth, Shanger Wang
  • Display screen or portion thereof with graphical user interface
    Patent number: D914717
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: March 30, 2021
    Assignee: DexCom, Inc.
    Inventors: Michael Robert Mensinger, Eric Cohen, Phil Mayou, Eli Reihman, Katherine Yerre Koehler, Rian Draeger, Angela Marie Traven
  • Medical device inserter
    Patent number: D914882
    Type: Grant
    Filed: October 28, 2019
    Date of Patent: March 30, 2021
    Assignee: DexCom, Inc.
    Inventors: Eric Gobrecht, Randall Scott Koplin, Kyle Neuser, Ryan Schoonmaker